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Corticotropin-releasing hormone (CRH) is a major mediator of stress responses in the 
brain-gut axis. Hypothalamic CRH secretion results in secretion of adrenocorticotropic 
hormone (ACTH) from the pituitary, which stimulates the adrenal gland to release cortisol. 
CRH receptors are widely distributed in the intestine as well as throughout the central 
nervous system1). Functional brain imaging studies with positron emission tomography 
(PET) and functional magnetic resonance imaging (fMRI) during visceral stimulation in 
IBS patients2) showed more activation in the insula, cingulate cortex, prefrontal cortices, 
amygdala, and hippocampus3) compared to healthy controls. In this study, we investigated 
the influence of CRH on HPA-axis and brain responses to visceral stimuli in IBS patients 
and healthy controls. Here, we hypothesized that exogenous administration of CRH in IBS 
patients is associated with increased responses in both the “visceral pain matrix”, especially 
the emotional-arousal network, and the ACTH-cortisol axes compared to healthy controls.  
 
We enrolled 16 male IBS patients and 16 male healthy subjects, and randomly 
divided them between CRH and saline injection groups. All of the IBS patients were 
diagnosed based on the Rome lll criteria4). The State-Trait Anxiety Inventory and 
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Self-Rating Depression Scale were used to assess their anxiety and depression levels and 
showed no significant differences between IBS and HC groups. This study was approved by 
the Ethics Committee of the Tohoku University Graduate School of Medicine, Japan. We 
used the barostat protocol. A bag was inserted into the colorectum. The catheter was then 
connected to computerized barostat equipment (Synectics Visceral Stimulator; Medtronics 
Synectics; Shoreview, MN). The patients randomly underwent no (0 mmHg), mild (20 
mmHg), or strong (40 mmHg) colorectal distension. CRH (2 µg/kg) or saline was then 
administered via injection, and the distention protocol was repeated. Blood samples were 
obtained from an intravenous cannula after each period, and subjective symptoms were 
evaluated using an ordinate scale2). rCBF in each subject was measured using a PET 
scanner in three-dimension sampling mode (HEADTOME V SET-2400W; Shimadzu, 
Kyoto, Japan). The scanner produced 63 transaxial slices with a thickness of 3.125 mm, an 
axial field of view of 200 mm, an in-plane resolution of 5.9 mm, full width at half 
maximum (FWHM), and an axial resolution of 3.9 mm FWHM. For each scan, 30 seconds 
after receiving injection of approximately 185 MBq of H215O intravenously through the 
right cubital vein, colorectal bag inflation was started. Data acquisition (70 s) began after 
barostat bag inflation. Plasma noradrenaline, adrenaline, ACTH, and cortisol levels were 
measured at the time of each distention. Data were analyzed using SPM8. ROIs were 
defined using the Wake Forest University (Winston-Salem, North Carolina) PickAtlas 
toolbox in SPM8 as follows: amygdala, hippocampus, insula, secondary/primary 
somatosensory cortex, anterior cingulate cortex, midcingulate cortex, thalamus, posterior 
cingulate cortex, medial prefrontal cortex, ventrolateral prefrontal cortex, dorsolateral 
prefrontal cortex, midbrain and pons. Active voxels for each ROI were considered 
statistically significant at a threshold of Family-Wise Error (FWE) corrected P < .05. An 
overall generalized estimating equation (GEE) analysis (SPSS 21.0, IBM Corp.) was 
performed during the random distention. 
 
The comparison between IBS patients and controls at baseline after CRH injection 
showed significantly higher activity in the right amygdala in IBS patients compared to 
controls in a regions of interest (ROI) analysis (t = 3.63, cluster [k] = 42, ROI PFWE-corr 
= .017; local maximum—x: 34, y: 2, z: -22) (Figure). There was no significant difference 
between IBS patients and controls for the contrast baseline after saline injection – baseline 
before saline injection. The controls receiving CRH injection showed significantly stronger 
activation in the amygdala, hippocampus and middle cingulate cortex at intense distention 
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compared to baseline compared to those receiving saline injection in a ROI analysis (Fig. 1). 
However, there were no differences in brain responses between IBS patients receiving CRH 
injection compared to patients receiving saline injection.  
The neuroendocrine changes after CRH or saline injection during random distention 
was analyzed using GEE. Plasma ACTH showed a significant drug effect (P < .001) and 
drug × distention interaction (P = .027) (Fig. 1). However, there was no significant 
difference between the two groups (IBS, controls). Serum cortisol levels showed a 
significant drug effect (P < .001), drug × distention interaction (P < .001) and drug × 
distention × group interaction (P = .001) (Fig. 1). 
During random distention after drug injection, ordinate scale showed a significant 
group effect in the abdominal pain scale (P < .001). All ordinate scales showed significant 
distention effects. 
 
We showed that exogenous administration of CRH modulates the increases in 
colorectal distention-induced activation of visceral sensation-related brain regions and 
neuroendocrine changes in both IBS patients and healthy controls. IBS patients had higher 
baseline activities in the amygdala, a key emotional-arousal area within the visceral pain 
networks, after CRH injection than controls. Rather, CRH increases colorectal 
distention-induced activity in the amygdala in healthy subjects but not IBS patients. Our 
findings suggest a ceiling response in the amygdala during CRH administration and 
colorectal distention in IBS patients and its synergetic activation of neuroendocrine 
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Figure 1.  Regional brain and neuroendocrine responses. (A) IBS patients showed significantly more activity 
than controls in the right amygdala at baseline after CRH injection compared with that at baseline before CRH 
injection. (B) Controls showed significantly greater activation than IBS patients in the right amygdala at 
intense distention after CRH injection compared with saline injection than IBS patients. (C) A significant drug 
effect and drug × distention interaction in plasma ACTH (pg/ml) and (D) a significant drug effect, drug × 
distention interaction and drug × distention × group interaction in serum cortisol during random distention 
after drug injection was noted between controls with saline (n = 8), IBS patients with saline (n= 8), controls 
with CRH (n = 8) and IBS patients with CRH (n = 8), analyzed by GEE. 
